EXPONENT, INC. vs CGI INC., two Consulting stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Exponent earns 32.2% on equity and 15.9% on assets with no debt at all, the cleanest capital-return profile in its cohort, the product of selling elite failure-analysis expertise billed by the hour. CGI earns 18% and 10.1%, respectable IT-services numbers, also debt-free. The market prices the specialist at 28.4 times earnings and the generalist at 11.8, and CGI answers with cash: a 10.5% free-cash yield nearly triple Exponent's 3.7%. Exponent adds a 2% dividend. The premium buys scarcity, consultants courts and regulators call by name; the discount buys volume. Both models work; only one is priced as if it might not.
Comparison updated 2026-07-10.
| Metric | EXPO | GIB |
|---|---|---|
| Price | $60.81 | $64.43 |
| Market cap | $3.0B | $14.7B |
| Sector | Consulting | Consulting |
| Stage | Mature | Mature |
| Implied growth (priced in) | +15.5% | — |
| P/E | 28.4 | 11.8 |
| P/B | 9.01 | 2.12 |
| P/S | 5.06 | 1.36 |
| EV/EBITDA | 23.1 | — |
| Revenue growth | +7.8% | +4.9% |
| Operating margin | 24.9% | — |
| Net margin | 18.1% | 11.5% |
| Return on equity | 32.2% | 17.9% |
| Return on assets | 15.8% | 10.1% |
| Return on invested capital | 24.1% | — |
| FCF yield | 3.7% | 10.5% |
| Dividend yield | 2.0% | — |
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.40 | 1.36 |
| Altman Z (solvency) | 8.05 | 3.22 |
| Piotroski F (quality) | 6 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.